Propensity‐score‐matched comparative analyses of simultaneously administered fixed‐ratio insulin glargine 100 U and lixisenatide (iGlarLixi) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetes

AIM: To conduct two exploratory analyses to compare indirectly the efficacy and safety of simultaneous administration of insulin glargine 100 U (iGlar) and the glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) lixisenatide (Lixi) as a single‐pen, titratable, fixed‐ratio combination (iGlarLixi [Lixi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenstock, Julio, Handelsman, Yehuda, Vidal, Josep, Ampudia Blasco, F. Javier, Giorgino, Francesco, Liu, Minzhi, Perfetti, Riccardo, Meier, Juris J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282993/
https://www.ncbi.nlm.nih.gov/pubmed/29974618
http://dx.doi.org/10.1111/dom.13462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282993/
https://www.ncbi.nlm.nih.gov/pubmed/29974618
http://dx.doi.org/10.1111/dom.13462

Ejemplares similares